(Q74685949)
Statements
Oral ganciclovir in the prevention of cytomegalovirus infection in postkidney transplant "CMV at risk" recipients: a controlled, comparative study of two regimens (750 mg Bid and 500 mg Bid) (English)
N Ahsan
M J Holman
L Sonderbye
E Langhoff